News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cell Therapeutics, Inc. (CTIC) to Present at the ROTH Capital Partners 25th Annual Growth Stock Conference


3/11/2013 6:46:43 AM

SEATTLE, March 11, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that management will present at the ROTH Capital Partners 25th Annual Growth Stock Conference on Monday, March 18, at 2:30 p.m. Pacific/ 5:30 p.m. Eastern/ 10:30 p.m. Central European time at the Ritz-Carlton Laguna Niguel in Dana Point, CA.

The presentation will also be webcast live and available for replay after the presentation. The webcast can be accessed at www.celltherapeutics.com.

About Cell Therapeutics, Inc.

Cell Therapeutics (NASDAQ and MTA: CTIC) is a biopharmaceutical company committed to the development and commercialization of an integrated portfolio of oncology products aimed at making cancer more treatable. CTI is headquartered in Seattle, WA. For additional information and to sign up for email alerts and get RSS feeds, please visit the company's website at www.CellTherapeutics.com.

CONTACT:

Monique Greer
+1-206-272-4343
mgreer@ctiseattle.com

Ed Bell
+1-206-282-7100
invest@ctiseattle.com

SOURCE Cell Therapeutics, Inc.


Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES